| Trial ID: | L0114 |
| Source ID: | NCT01720719
|
| Associated Drug: |
Vitamin E
|
| Title: |
Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease
|
| Acronym: |
--
|
| Status: |
Unknown status
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Fatty Liver|Dyslipidemias|Diabetes Mellitus
|
| Interventions: |
Drug: atorvastatin|Drug: Vitamin E
|
| Outcome Measures: |
Liver fat content(%)|Abdominal visceral fat area(cm2)|Abdominal subcutaneous fat area(cm2)|Lipid profiles|Liver enzymes|Glucose metabolism|Body weight|Anthropometric test|Muscle enzymes
|
| Sponsor/Collaborators: |
Xin Gao|Pfizer|Fudan University
|
| Gender: |
All
|
| Age: |
18 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
120
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
May 2013
|
| Completion Date: |
December 2016
|
| Results First Posted: |
--
|
| Last Update Posted: |
February 3, 2016
|
| Locations: |
Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China
|
| URL: |
https://ClinicalTrials.gov/show/NCT01720719
|
